{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:07:04Z","timestamp":1772752024718,"version":"3.50.1"},"reference-count":72,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1210\/en.2017-00416","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T18:04:04Z","timestamp":1501524244000},"page":"3592-3604","source":"Crossref","is-referenced-by-count":21,"title":["Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II\u2013Induced Cardiac Diastolic Dysfunction in Male Mice"],"prefix":"10.1210","volume":"158","author":[{"given":"Scott M","family":"Brown","sequence":"first","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Department of Biomedical Sciences, University of Missouri, Columbia, Missouri 65211"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra E","family":"Smith","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex I","family":"Meuth","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Department of Biomedical Sciences, University of Missouri, Columbia, Missouri 65211"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maloree","family":"Khan","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Department of Biomedical Sciences, University of Missouri, Columbia, Missouri 65211"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annayya R","family":"Aroor","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah M","family":"Cleeton","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Department of Biomedical Sciences, University of Missouri, Columbia, Missouri 65211"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald A","family":"Meininger","sequence":"additional","affiliation":[{"name":"Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211"},{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R","family":"Sowers","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, University of Missouri School of Medicine, Columbia, Missouri 65212"},{"name":"Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211"},{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent G","family":"DeMarco","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, University of Missouri School of Medicine, Columbia, Missouri 65212"},{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bysani","family":"Chandrasekar","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211"},{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri 65212"},{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Nistala","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Division of Nephrology, University of Missouri School of Medicine, Columbia, Missouri 65212"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn B","family":"Bender","sequence":"additional","affiliation":[{"name":"Research, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201"},{"name":"Department of Biomedical Sciences, University of Missouri, Columbia, Missouri 65211"},{"name":"Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"issue":"4","key":"2019041121323580600_B1","first-page":"e29","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"2019041121323580600_B2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","article-title":"Diabetic cardiomyopathy: bench to bedside","volume":"8","author":"Schilling","year":"2012","journal-title":"Heart Fail Clin"},{"issue":"6","key":"2019041121323580600_B3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.111.066423","article-title":"Impact of progression of diastolic dysfunction on mortality in patients with normal ejection fraction","volume":"125","author":"Aljaroudi","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"2019041121323580600_B4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1524-6175.2005.04889.x","article-title":"Role of angiotensin II in the evolution of diastolic heart failure","volume":"7","author":"Chinnaiyan","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"2019041121323580600_B5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"2019041121323580600_B6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10741-015-9506-7","article-title":"Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review","volume":"20","author":"Lekavich","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"4","key":"2019041121323580600_B7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1517\/14728210802584126","article-title":"Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes","volume":"13","author":"Ahr\u00e9n","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"2019041121323580600_B8","doi-asserted-by":"crossref","first-page":"e003277","DOI":"10.1161\/JAHA.116.003277","article-title":"Saxagliptin and tadalafil differentially alter cyclic guanosine monophosphate (cGMP) signaling and left ventricular function in aortic-banded mini-swine","volume":"5","author":"Hiemstra","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2019041121323580600_B9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fphys.2016.00293","article-title":"Dipeptidyl peptidase IV inhibition exerts renoprotective effects in rats with established heart failure","volume":"7","author":"Arruda-Junior","year":"2016","journal-title":"Front Physiol"},{"issue":"1","key":"2019041121323580600_B10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1753-0407.12258","article-title":"Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: role of stromal cell-derived factor-1\u03b1","volume":"8","author":"Connelly","year":"2016","journal-title":"J Diabetes"},{"issue":"4","key":"2019041121323580600_B11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"Sauv\u00e9","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"2019041121323580600_B12","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/en.2013-1096","article-title":"Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats","volume":"154","author":"Aroor","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"2019041121323580600_B13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.metabol.2014.04.002","article-title":"Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity","volume":"63","author":"Bostick","year":"2014","journal-title":"Metabolism"},{"issue":"1","key":"2019041121323580600_B14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jphs.2016.08.008","article-title":"Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats","volume":"132","author":"Ikeda","year":"2016","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"2019041121323580600_B15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat-fed diabetic mice","volume":"65","author":"Mulvihill","year":"2016","journal-title":"Diabetes"},{"issue":"14","key":"2019041121323580600_B16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"2019041121323580600_B17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"2019041121323580600_B18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-016-0599-5","article-title":"MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-\u03baB signaling pathway","volume":"112","author":"Han","year":"2017","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"2019041121323580600_B19","doi-asserted-by":"crossref","first-page":"e003126","DOI":"10.1161\/JAHA.115.003126","article-title":"Intercellular adhesion molecule 1 regulates left ventricular leukocyte infiltration, cardiac remodeling, and function in pressure overload-induced heart failure","volume":"5","author":"Salvador","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2019041121323580600_B20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"4","key":"2019041121323580600_B21","doi-asserted-by":"crossref","first-page":"H477","DOI":"10.1152\/ajpheart.00209.2014","article-title":"Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system","volume":"307","author":"Aroor","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2019041121323580600_B22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12933-017-0544-4","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice","volume":"16","author":"Aroor","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2019041121323580600_B23","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1074\/jbc.M116.764522","article-title":"Targeting TRAF3IP2 by genetic and interventional approaches inhibits ischemia\/reperfusion-induced myocardial injury and adverse remodeling","volume":"292","author":"Erikson","year":"2017","journal-title":"J Biol Chem"},{"issue":"37","key":"2019041121323580600_B24","doi-asserted-by":"crossref","first-page":"19425","DOI":"10.1074\/jbc.M116.724138","article-title":"Cardiac-restricted overexpression of TRAF3 interacting protein 2 (TRAF3IP2) results in spontaneous development of myocardial hypertrophy, fibrosis, and dysfunction","volume":"291","author":"Yariswamy","year":"2016","journal-title":"J Biol Chem"},{"issue":"10","key":"2019041121323580600_B25","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cellsig.2015.07.001","article-title":"Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2","volume":"27","author":"Somanna","year":"2015","journal-title":"Cell Signal"},{"issue":"1","key":"2019041121323580600_B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12781","article-title":"Cut to the chase: a review of CD26\/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system","volume":"185","author":"Klemann","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2019041121323580600_B27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2012.09.012","article-title":"An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease","volume":"226","author":"Zhong","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"2019041121323580600_B28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0976-500X.85934","article-title":"Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus","volume":"2","author":"Dave","year":"2011","journal-title":"J Pharmacol Pharmacother"},{"issue":"5","key":"2019041121323580600_B29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.115.06172","article-title":"Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure","volume":"66","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"2019041121323580600_B30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/HYPERTENSIONAHA.114.04912","article-title":"Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction","volume":"65","author":"Bender","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"2019041121323580600_B31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","article-title":"Low-dose mineralocorticoid receptor blockade prevents Western diet-induced arterial stiffening in female mice","volume":"66","author":"DeMarco","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"2019041121323580600_B32","doi-asserted-by":"crossref","first-page":"H574","DOI":"10.1152\/ajpheart.00155.2015","article-title":"Regional variation in arterial stiffening and dysfunction in Western diet-induced obesity","volume":"309","author":"Bender","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"2019041121323580600_B33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/HYPERTENSIONAHA.116.07954","article-title":"Regular exercise reduces endothelial cortical stiffness in Western diet-fed female mice","volume":"68","author":"Padilla","year":"2016","journal-title":"Hypertension"},{"key":"2019041121323580600_B34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-61779-523-7_22","volume-title":"Cardiovascular Development: Methods and Protocols","author":"Wu","year":"2012"},{"key":"2019041121323580600_B35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2210-12-2","article-title":"Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Pharmacol"},{"key":"2019041121323580600_B36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2016.04.005","article-title":"Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats","volume":"783","author":"Uchii","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2019041121323580600_B37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2015.04.023","article-title":"Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats","volume":"761","author":"Sakai","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"2019041121323580600_B38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/aps.2016.72","article-title":"Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"2019041121323580600_B39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5551\/jat.27292","article-title":"Angiotensin II activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4","volume":"22","author":"Matsuda","year":"2015","journal-title":"J Atheroscler Thromb"},{"issue":"11","key":"2019041121323580600_B40","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","article-title":"Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance","volume":"62","author":"Aroor","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"2019041121323580600_B41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cellsig.2012.10.009","article-title":"CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunction","volume":"25","author":"Venkatesan","year":"2013","journal-title":"Cell Signal"},{"issue":"19","key":"2019041121323580600_B42","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1073\/pnas.190245697","article-title":"CIKS, a connection to Ikappa B kinase and stress-activated protein kinase","volume":"97","author":"Leonardi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019041121323580600_B43","doi-asserted-by":"crossref","first-page":"e003688","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688","article-title":"Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure","volume":"10","author":"Bansal","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"4","key":"2019041121323580600_B44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.115.06004","article-title":"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin \u03b1V\u03b23\/nuclear factor-\u03baB\/interleukin-6 axis","volume":"66","author":"Shimojo","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"2019041121323580600_B45","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.114.04803","article-title":"Cytosolic phospholipase A2\u03b1 is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology","volume":"65","author":"Khan","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"2019041121323580600_B46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/CS20120619","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats","volume":"126","author":"Gonz\u00e1lez","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"2019041121323580600_B47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/HYPERTENSIONAHA.115.06262","article-title":"Excessive adventitial remodeling leads to early aortic maladaptation in angiotensin-induced hypertension","volume":"67","author":"Bersi","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"2019041121323580600_B48","doi-asserted-by":"crossref","first-page":"e0124013","DOI":"10.1371\/journal.pone.0124013","article-title":"Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness","volume":"10","author":"Eberson","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"2019041121323580600_B49","doi-asserted-by":"crossref","first-page":"H1287","DOI":"10.1152\/ajpheart.00096.2016","article-title":"Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension","volume":"311","author":"Gonz\u00e1lez","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"2019041121323580600_B50","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121323580600_B51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2014.11.027","article-title":"Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis","volume":"185","author":"Falkenham","year":"2015","journal-title":"Am J Pathol"},{"issue":"5","key":"2019041121323580600_B52","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.114.04067","article-title":"Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL\/6 mouse substrains","volume":"64","author":"Cardin","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"2019041121323580600_B53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1291\/hypres.28.483","article-title":"Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis","volume":"28","author":"Kai","year":"2005","journal-title":"Hypertens Res"},{"issue":"4","key":"2019041121323580600_B54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","article-title":"Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?","volume":"43","author":"Kuwahara","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"2019041121323580600_B55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10557-015-6592-7","article-title":"Preservation of glucagon-like peptide-1 level attenuates angiotensin ii-induced tissue fibrosis by altering AT1\/AT 2 receptor expression and angiotensin-converting enzyme 2 activity in rat heart","volume":"29","author":"Zhang","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"2019041121323580600_B56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/nep.12618","article-title":"Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes","volume":"21","author":"Gangadharan Komala","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"2019041121323580600_B57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20080390","article-title":"Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction","volume":"116","author":"Sciarretta","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"19","key":"2019041121323580600_B58","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1073\/pnas.160265197","article-title":"Act1, an NF-\u03ba B-activating protein","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121323580600_B59","doi-asserted-by":"crossref","first-page":"A8420","DOI":"10.1161\/circ.124.suppl_21.A8420","article-title":"Abstract 8420: critical role of CIKS\/Act1 in lipopolysaccharide (LPS)-induced cardiac dysfunction in vivo and cardiomyocyte contractility in vitro","volume":"124","author":"Valente","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"2019041121323580600_B60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yjmcc.2012.04.009","article-title":"CIKS (Act1 or TRAF3IP2) mediates angiotensin-ii-induced interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy","volume":"53","author":"Valente","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2019041121323580600_B61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00395-017-0615-4","article-title":"Role of bone marrow-derived CD11c(+) dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy","volume":"112","author":"Wang","year":"2017","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"2019041121323580600_B62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1189\/jlb.0408256","article-title":"CD11c identifies a subset of murine liver natural killer cells that responds to adenoviral hepatitis","volume":"84","author":"Burt","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"11","key":"2019041121323580600_B63","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1084\/jem.20070991","article-title":"Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells","volume":"204","author":"Blasius","year":"2007","journal-title":"J Exp Med"},{"key":"2019041121323580600_B64","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002761","article-title":"Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration","volume-title":"Sci Transl Med","author":"Huynh","year":"2011"},{"issue":"7","key":"2019041121323580600_B65","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4049\/jimmunol.162.7.3840","article-title":"Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling","volume":"162","author":"Rabin","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"2019041121323580600_B66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/cimm.2001.1890","article-title":"Stimulation of T-Cell activation by CXCL12\/stromal cell derived factor-1 involves a G-protein mediated signaling pathway","volume":"214","author":"Nanki","year":"2001","journal-title":"Cell Immunol"},{"key":"2019041121323580600_B67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.imlet.2017.02.012","article-title":"Understanding memory CD8(+) T cells","volume":"185","author":"Samji","year":"2017","journal-title":"Immunol Lett"},{"issue":"2","key":"2019041121323580600_B68","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4049\/jimmunol.1000661","article-title":"Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells","volume":"185","author":"Dai","year":"2010","journal-title":"J Immunol"},{"issue":"9","key":"2019041121323580600_B69","doi-asserted-by":"crossref","first-page":"e45234","DOI":"10.1371\/journal.pone.0045234","article-title":"Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-\u03b3-mediated suppressor activities","volume":"7","author":"Bahri","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2019041121323580600_B70","doi-asserted-by":"crossref","first-page":"884","DOI":"10.4049\/jimmunol.0903287","article-title":"Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life","volume":"185","author":"Dubois","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"2019041121323580600_B71","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.4049\/jimmunol.1501232","article-title":"Depletion of CD8+ T cells exacerbates CD4+ T cell-induced monocyte-to-fibroblast transition in renal fibrosis","volume":"196","author":"Dong","year":"2016","journal-title":"J Immunol"},{"issue":"18","key":"2019041121323580600_B72","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","article-title":"Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial","volume":"130","author":"Scirica","year":"2014","journal-title":"Circulation"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/10\/3592\/20424862\/en.2017-00416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:59:49Z","timestamp":1719352789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/10\/3592\/4056264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":72,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,7,31]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2017-00416","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,7,31]]}}}